Cargando…
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA
BACKGROUND: Disease burden and associated costs are not well understood among patients with gastroesophageal reflux disease (GERD) who have persistent symptoms despite optimized proton pump inhibitor (PPI) therapy. The aim of this study was to investigate disease burden and costs of GERD in partial...
Autores principales: | Stålhammar, Nils-Olov, Spiegel, Brennan M, Granstedt Löfman, Helena, Karlsson, Maria, Wahlqvist, Peter, Næsdal, Jørgen, Nelson, M Todd, Despiégel, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045010/ https://www.ncbi.nlm.nih.gov/pubmed/27774018 http://dx.doi.org/10.2147/POR.S36704 |
Ejemplares similares
-
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France
por: Bruley des Varannes, Stanislas, et al.
Publicado: (2013) -
Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial
por: Trad, Karim S., et al.
Publicado: (2015) -
Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018) -
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
por: Mody, Reema, et al.
Publicado: (2013) -
Defining GERD.
por: Sontag, S. J.
Publicado: (1999)